Product Image

Boswellia 307 mg

4.6
★ ★ ★ ★ ★
(2274 ratings)
Boswellia 307 mg
Product Image
Score76
A useful, convenient extract serving offers fair value, while unquantified active markers limit potency confidence.
How scoring works
Tablet
Quantity:60 Tablet(s) • (60 servings)
Goals:
Joint Health
Anti-Inflammatory Support

Score 76

A useful, convenient extract serving offers fair value, while unquantified active markers limit potency confidence.
How scoring works
$14.99($0.24 per serving)
iHerb
$ 15.49
Vitacost
$ 15.49
Pure Formulas
$ 15.49
Amazon
$ 14.99
iHerb
$ 14.99
Vitacost
$ 15.49
Report prices

Analysis

A single 307 mg Boswellia serrata gum-resin extract gives the tablet clear relevance to joint comfort. The focused formula avoids spreading the serving across unrelated ingredients.

Boswellic acids are named as the form, but their percentage and the AKBA content are not provided. The tablet also lacks a stated lipid carrier or other absorption enhancer.

One tablet per serving and an accessible ongoing cost support routine use. It is best viewed as a basic extract option for users who can accept incomplete potency data.

Who is it for
  • Adults seeking a basic Boswellia extract
  • People who prefer one tablet daily
  • Value-minded users comfortable with partial label detail
Best for
  • Focused joint-comfort support
  • Simple daily use
  • Affordable extract supplementation

Pros

  • Useful 307 mg extract amount
  • Single-active formula
  • Convenient low-cost serving

Cons

  • No total boswellic-acid percentage
  • AKBA content is not stated
  • No absorption-enhancing delivery

Warnings

  • Boswellia can cause nausea, heartburn, or loose stools.
  • Boswellia may increase bleeding tendency with anticoagulant or antiplatelet medicines.
  • The tablet may be unsuitable if gum-resin botanicals have previously caused an allergic reaction.

Nutrient quality

78 High impact

A useful resin-extract amount directly fits the intended use. Missing active-acid percentages and absorption support limit potency assurance.

.

Ingredient transparency

75 High impact

The extract amount is disclosed without a hidden blend. Intake directions, inactive ingredients, and active-acid strength are absent.

.

Customer satisfaction

68 High impact

The supplied average rating is strong and comes from a substantial rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.

Value for money

80 Highest impact

A useful extract amount and modest serving cost provide good basic value. Missing standardization keeps quality-based competitiveness moderate.

.
Report analysis

Goals

Joint Health
Joint Health
Impact
High effect
A- Goal FitC+ Strength of SupportC- CoverageA+ Formula Quality
Boswellia · 307 mg

Boswellia directly targets inflammatory pathways involved in joint comfort, and the extract amount is substantial. The label names boswellic acids but does not state their percentage, so active potency cannot be confirmed.

The focused formula has strong depth for one mechanism but does not add cartilage building blocks or lubrication support. Its single-active design is clean and well aligned with joint use.

Study evidence
Boswellia Supportive 24 studies
Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
High effect
A- Goal FitC Strength of SupportD CoverageA+ Formula Quality
Boswellia · 307 mg

Boswellia serrata directly targets the 5-LOX pathway and may support joint comfort. The 307 mg extract weight is useful, but human effects depend heavily on boswellic-acid and AKBA content.

No standardization percentage, AKBA level, or absorption enhancer is disclosed. The focused formula remains relevant, but its true active potency cannot be confirmed from the label.

Study evidence
Boswellia Supportive 19 studies

Ingredients

IngredientAmount per serving
Total Carbohydrates
1 Gram(s)
Boswellia serrata gum resin extract (Boswellic Acids)
 307 mg
Gluten Free Adults 18–50 Vegan Dairy Free Sugar Free Vegetarian
Report overview
Boswellia (Boswellic Acids) · 307 mg OverallScore49
F Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyB- Value

The 307 mg resin extract provides a useful amount, but the label does not state its boswellic-acid percentage or AKBA content. No absorption enhancer or lipid delivery system is listed for the tablet. The low serving cost supports value, although the unknown concentration prevents a top quality assessment.

View ingredientView products
Loading alternative details
84 Performance

Boswellia Extract 500 mg

California Gold Nutrition
<p>For a stronger ingredient and goal fit, a substantial branded boswellia extract and concentrated turmeric create strong joint-focused coverage. Compared with the original, it remains a focused Boswellia option; boswellic-acid and curcuminoid percentages remain partly unclear.</p>
83 Performance

Boswellia AKBA

Pure Encapsulations
<p>For a stronger ingredient and goal fit, a recognized 5-LOXIN extract provides a focused high-AKBA Boswellia source at a practical amount. Compared with the original, it remains a focused Boswellia option; efficient serving value offsets the absence of an explicit active-acid percentage and separate absorption aid.</p>
82 Performance

Boswellia 400 mg

Nature's Answer
<p>For a stronger ingredient and goal fit, a focused 400 mg Boswellia extract offers a practical amount and favorable serving value. Compared with the original, it remains a focused Boswellia option; missing boswellic-acid strength and lack of absorption support keep the quality basic.</p>
81 Budget

Boswellia Extract 600 mg

Herbal Secrets
<p>At a lower serving cost than the original, a focused Boswellia extract supplies a substantial amount at an efficient serving cost. Compared with the original, it remains a focused Boswellia option; missing boswellic-acid and AKBA percentages limit confidence in potency, and no enhanced delivery method is identified.</p>
81 Budget

Boswellia Extract 500 mg

NOW
<p>At a lower serving cost than the original, a substantial Boswellia amount, lipid delivery, and low serving cost create strong basic value, though active-acid percentages remain unclear. Compared with the original, it remains a focused Boswellia option; boswellia may increase bleeding tendency with anticoagulant or antiplatelet medicines.</p>
81 Budget

Boswellia Serrata

Swanson
<p>At a lower serving cost than the original, a substantial combination of whole Boswellia and a named extract provides focused support and strong value, though active-acid percentages are absent. Compared with the original, it remains a focused Boswellia option; boswellia may increase bleeding tendency with anticoagulant or antiplatelet medicines.</p>
79 Value

Boswellia Extract

SuperiorLabs
<p>For a more favorable quality-to-cost balance, a substantial frankincense extract with black pepper creates a focused inflammation and joint-support formula at a favorable recurring cost. Compared with the original, it remains a focused Boswellia option; missing boswellic-acid and AKBA percentages limit potency comparison, while the small leucine amount adds little independent value.</p>
78 Value

Boswellia Resin Extract

Solgar
<p>For a more favorable quality-to-cost balance, a substantial extract-plus-powder serving provides focused Boswellia support and good basic value, though active-acid percentages are missing. Compared with the original, it remains a focused Boswellia option; boswellia may increase bleeding tendency when combined with anticoagulant or antiplatelet medicines.</p>
79 Value

Boswellia Serrata Extract 125 mg

Swanson Ultra
<p>For a more favorable quality-to-cost balance, a practical amount of a specialized high-AKBA Boswellia extract creates a focused formula with good value, though the active percentage is not stated. Compared with the original, it remains a focused Boswellia option; boswellia may increase bleeding tendency with anticoagulant or antiplatelet medicines.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsJoint Health Anti-Inflammatory Support forBoswellia
  2. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsJoint Health Anti-Inflammatory Support forBoswellia
  3. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  4. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsJoint Health Anti-Inflammatory Support forBoswellia
  5. Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis.
    Zhang Y; Gui Y; Adams R; Farragher J; Itsiopoulos C; Bow K; Cai M; Han J · Nutrients · 2025
    Meta-analysis4,599 participants39 studies pooledJoint Health forBoswellia
  6. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health forBoswellia
  7. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.
    Sengupta K; Krishnaraju AV; Vishal AA; Mishra A; Trimurtulu G; Sarma KV; Raychaudhuri SK; Raychaudhuri SP · International journal of medical sciences · 2011
    Randomized trial60 participantsJoint Health forBoswellia
  8. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis.
    Bannuru RR; Osani MC; Al-Eid F; Wang C · Seminars in arthritis and rheumatism · 2019
    Meta-analysis1,009 participants11 studies pooledJoint Health forBoswellia
  9. Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study.
    Karlapudi V; Sunkara KB; Konda PR; Sarma KV; Rokkam MP · Journal of the American Nutrition Association · 2023
    Randomized trial70 participantsJoint Health forBoswellia
  10. Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.
    Dalmonte T; Andreani G; Rudelli C; Isani G · Phytotherapy research : PTR · 2024
    Meta-analysis1,185 participants13 studies pooledJoint Health forBoswellia
  11. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  12. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  13. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia